Published in Biochem Biophys Res Commun on August 30, 1994
Np95 is a histone-binding protein endowed with ubiquitin ligase activity. Mol Cell Biol (2004) 2.35
Cluster analysis of mass spectrometry data reveals a novel component of SAGA. Mol Cell Biol (2004) 2.22
Haploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability. Am J Hum Genet (2012) 2.12
Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. Proc Natl Acad Sci U S A (2002) 1.89
Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Mol Cell Biol (2001) 1.70
Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. Mol Cell Biol (2010) 1.39
The dose of a putative ubiquitin-specific protease affects position-effect variegation in Drosophila melanogaster. Mol Cell Biol (1996) 1.12
Histones of Chlamydomonas reinhardtii. Synthesis, acetylation, and methylation. Plant Physiol (1995) 1.01
The ubiquitin-conjugating enzyme HR6B is required for maintenance of X chromosome silencing in mouse spermatocytes and spermatids. BMC Genomics (2010) 0.92
Psoriasin (S100A7) expression and invasive breast cancer. Am J Pathol (1999) 1.56
Altered estrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res (1998) 1.46
The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res (1999) 1.37
Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res (1985) 1.37
Level of ubiquitinated histone H2B in chromatin is coupled to ongoing transcription. Biochemistry (1990) 1.37
Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol (1987) 1.36
Expression of estrogen receptor-beta in human breast tumors. J Clin Endocrinol Metab (1997) 1.34
Estrogen receptor-beta messenger RNA expression in human breast tumor biopsies: relationship to steroid receptor status and regulation by progestins. Cancer Res (1999) 1.34
Expression of lumican in human breast carcinoma. Cancer Res (1998) 1.33
Expression of the steroid receptor RNA activator in human breast tumors. Cancer Res (1999) 1.32
Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma. Cancer Res (1996) 1.31
Expression of oestrogen receptor-beta in oestrogen receptor-alpha negative human breast tumours. Br J Cancer (2006) 1.29
High-affinity anti-oestrogen binding site distinct from the oestrogen receptor. Nature (1980) 1.29
Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue. Cancer Res (1999) 1.23
Lumican and decorin are differentially expressed in human breast carcinoma. J Pathol (2000) 1.21
Psoriasin (S100A7). Int J Biochem Cell Biol (1998) 1.20
Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol (1992) 1.18
Putative functional characteristics of human estrogen receptor-beta isoforms. J Mol Endocrinol (2003) 1.17
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. III. Hormone receptor status and responsiveness. J Natl Cancer Inst (1984) 1.14
Multiple functions of dynamic histone acetylation. J Cell Biochem (1994) 1.10
Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Cancer Res (1983) 1.02
Estrogen receptor-beta mRNA variants in human and murine tissues. Mol Cell Endocrinol (1998) 1.02
The nuclear matrix and the regulation of chromatin organization and function. Int Rev Cytol (1995) 0.99
Mechanisms of oestrogen antagonism by nonsteroidal antioestrogens. Mol Cell Endocrinol (1982) 0.99
Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst (1996) 0.99
Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer. Carcinogenesis (1992) 0.99
Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen. Cancer Res (1984) 0.96
Microsomal binding sites for nonsteroidal anti-estrogens in MCF 7 human mammary carcinoma cells. Demonstration of high affinity and narrow specificity for basic ether derivatives of triphenylethylene. J Biol Chem (1984) 0.96
Measurement of the relative binding affinity of zearalenone, alpha-zearalenol and beta-zearalenol for uterine and oviduct estrogen receptors in swine, rats and chickens: an indicator of estrogenic potencies. Comp Biochem Physiol C (1989) 0.94
Role of wild-type estrogen receptor-beta in mitochondrial cytoprotection of cultured normal male and female human lens epithelial cells. Am J Physiol Endocrinol Metab (2008) 0.94
Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers. Histopathology (2008) 0.93
Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol (1999) 0.93
Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res (1986) 0.90
Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site. J Clin Endocrinol Metab (1983) 0.88
The binding of tamoxifen to human mammary carcinoma cytosol. Eur J Cancer (1980) 0.88
Identification of differentially expressed genes using minute amounts of RNA. Biotechniques (1996) 0.87
Biological actions of prolactin in human breast cancer. Recent Prog Horm Res (1987) 0.87
Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Res (1984) 0.87
Elevated mitogen-activated protein kinase activity in estrogen-nonresponsive human breast cancer cells. Cancer Res (1998) 0.87
Estrogen induction of N-myc and c-myc proto-oncogene expression in the rat uterus. Endocrinology (1987) 0.87
Identification of a serum-inducible messenger RNA (5B10) as the mouse homologue of calcyclin: tissue distribution and expression in metastatic, ras-transformed NIH 3T3 cells. Cell Growth Differ (1990) 0.87
Estrogen regulates the association of intermediate filament proteins with nuclear DNA in human breast cancer cells. J Biol Chem (1998) 0.86
A high-affinity binding site for the antioestrogens, tamoxifen and CI 628, in immature rat uterine cytosol which is distinct from the oestrogen receptor. J Endocrinol (1981) 0.85
A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion. Breast Cancer Res Treat (1997) 0.85
Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res (1990) 0.85
Expression of estrogen receptor variant messenger RNAs and determination of estrogen receptor status in human breast cancer. Am J Pathol (1997) 0.85
Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers. Cancer Res (2000) 0.85
Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro. Endocrinology (1985) 0.84
Estrogen regulation of nuclear matrix-intermediate filament proteins in human breast cancer cells. J Cell Biochem (1996) 0.84
Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene. J Cell Biochem (1996) 0.83
Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res (1996) 0.83
The knee-chest position does not improve the efficacy of ipecac-induced emesis. Am J Emerg Med (1989) 0.83
Hormonal regulation of proliferation and transforming growth factors gene expression in human endometrial adenocarcinoma xenografts. J Steroid Biochem Mol Biol (1994) 0.82
Functional characteristics of a novel murine estrogen receptor-beta isoform, estrogen receptor-beta 2. J Mol Endocrinol (2000) 0.81
Timing of the appearance of ubiquitinated histones in developing new macronuclei of Tetrahymena thermophila. Biochem Cell Biol (1991) 0.81
Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res (1987) 0.81
Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells. Cell Growth Differ (1992) 0.80
C-myc gene chromatin of estrogen receptor positive and negative breast cancer cells. Mol Cell Endocrinol (1993) 0.80
Altered expression of estrogen receptor-alpha variant messenger RNAs between adjacent normal breast and breast tumor tissues. Breast Cancer Res (2000) 0.80
Phorbol esters differentially regulate the expression of insulin-like growth factor-binding proteins in endometrial carcinoma cells. Endocrinology (1992) 0.80
Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. J Clin Endocrinol Metab (1986) 0.80
Characterization and chromatin distribution of the H1 histones and high-mobility-group non-histone chromosomal proteins of trout liver and hepatocellular carcinoma. Biochem J (1991) 0.80
Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins. Cancer Res (1991) 0.79
Estrogen receptor diminishes DNA-binding activities of chicken GATA-1 and CACCC-binding proteins. DNA Cell Biol (1997) 0.79
Differential regulation of c-myc by progestins and antiestrogens in T-47D human breast cancer cells. J Steroid Biochem Mol Biol (1991) 0.79
Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue. Biochem Biophys Res Commun (1996) 0.79
Effects of transforming growth factors and regulation of their mRNA levels in two human endometrial adenocarcinoma cell lines. J Steroid Biochem Mol Biol (1992) 0.78
Oestrogen receptor-alpha variant mRNA expression in primary human breast tumours and matched lymph node metastases. Br J Cancer (1999) 0.78
Estrogen receptor beta: mine is longer than yours? J Clin Endocrinol Metab (1998) 0.78
Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Cancer Res (1992) 0.78
Growth factors in normal and malignant uterine tissue. Ann N Y Acad Sci (1991) 0.78
Altered expression of exon 6 deleted progesterone receptor variant mRNA between normal human breast and breast tumour tissues. Br J Cancer (1999) 0.78
Modifications in the aminoether side chain of clomiphene influence affinity for a specific antiestrogen binding site in MCF 7 cells cytosol. Biochem Biophys Res Commun (1981) 0.78
Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogens. Breast Cancer Res Treat (1994) 0.78
Influence of estrogen receptor variants on the determination of ER status in human breast cancer. Breast Cancer Res Treat (1999) 0.78
Regulation of c-jun and jun-B by progestins in T-47D human breast cancer cells. Mol Endocrinol (1992) 0.77
Variant estrogen receptor-alpha messenger RNA expression in hormone-independent human breast cancer cells. J Mol Endocrinol (1999) 0.77
Estrogen receptor-alpha mRNA variants in murine and human tissues. Mol Cell Endocrinol (1999) 0.76
Regulation of transforming growth factor gene expression in human endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol (1992) 0.76
25-Hydroxycholecalciferol receptors in human breast cancer. Br J Cancer (1979) 0.75
Actions of pituitary prolactin and insulin-like growth factor II in human breast cancer. Cancer Treat Res (1988) 0.75
A role for the insulin-like growth factors as estromedins in the rat uterus. Trans Assoc Am Physicians (1987) 0.75
Proceedings: Uptake and metabolism of (3H)progesterone by the uterus of the ovariectomized mouse. J Reprod Fertil (1976) 0.75
The role of dipsticks in the diagnosis of urinary tract infection. Ir Med J (1989) 0.75
The path of screw insertion for stabilization of the scapholunate joint: a cadaveric study. Hand Surg (2014) 0.75
Partial palatomaxillary core ostectomy with multiple flap reconstruction. Head Neck Surg (1986) 0.75
Mandatory health insurance coverage for cancer clinical trials. McGeorge Law Rev (2005) 0.75
Stabilisation of the cytoplasmic oestrogen receptor by molybdate. J Steroid Biochem (1981) 0.75
The interaction of estrogen- and antiestrogen-receptor complexes with polynucleotides. Endocrinology (1983) 0.75
The path of screw insertion for stabilization of the scapholunate joint. A radiological study. J Hand Surg Eur Vol (2012) 0.75
Antigenic reactivity of ribosomal protein S6 and the calcium-binding ATPase inhibitor protein of mammalian mitochondria. Mol Cell Biochem (1991) 0.75
The effect of estradiol on a 25-hydroxycholecalciferol binding protein in the uterus of the mouse. Steroids (1980) 0.75
Enhanced c-jun activity alters responsiveness to medroxyprogesterone acetate in Ishikawa human endometrial carcinoma cells. Mol Endocrinol (1993) 0.75